Area of research
Epidemiology · Cancer Research
Research interest
Research interests include PI3K/AKT/mTOR pathway, Autophagy, Protein kinase B, Sorafenib, Cancer research, and Medicine.
Hierarchical SnS2@CNFs composite with 3D structure for high-performance aluminum-ion batteries: Unveiling Al3+ deintercalation mechanism through first-principles calculations
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis
Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non‐alcoholic fatty liver disease by up‐regulating the FGF21/PGC‐1α pathway
Alleviation of hepatic fibrosis and autophagy via inhibition of transforming growth factor‐<b>β</b>1/Smads pathway through shikonin
Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways
Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death
By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma
The protective effects of shikonin on hepatic ischemia/reperfusion injury are mediated by the activation of the PI3K/Akt pathway
Salidroside pretreatment attenuates apoptosis and autophagy during hepatic ischemia&ndash;reperfusion injury by inhibiting the mitogen-activated protein kinase pathway in mice
The long noncoding RNA TUG1 acts as a competing endogenous RNA to regulate the Hedgehog pathway by targeting miR-132 in hepatocellular carcinoma
Pretreatment with propylene glycol alginate sodium sulfate ameliorated concanavalin A-induced liver injury by regulating the PI3K/Akt pathway in mice